Home Technology Executives share 7 Life Sciences Predictions to Look Out For in 2023

Executives share 7 Life Sciences Predictions to Look Out For in 2023


Tracy Curley is the interim CEO of iSpecimen and CFO.

The macroeconomic environment is what we should be focusing on. It remains affected by the COVID-19 pandemic. There is still uncertainty about the strength and viability of the US, UK, Asia Pacific, UK, and global economies. All market participants remain concerned about high-interest rates as well as a possible recession. ISPC is closely monitoring the speed of specimen transactions. This industry is capable of surviving a continuing economic downturn, recession, and any inflation-related impacts.

Capricor Therapeutics CEO, Dr. Linda Marban

For the first time in a long time, we are seeing the emergence of three new viral infections: RSV, the flu, and COVID – all of these viral syndromes that were sitting dormant while the world was locked down for COVID-19. With this triple threat, I believe that industry will be able to start to address how they manage infectious diseases. The focus was initially on COVID.

Ariel Katz, CEO & Co-Founder at H1

Diversity is key to drug approvals, and development. FDA and other governing body will hold pharma companies more accountable for diversity…

Continue reading…

Previous articleTwitter users report bugs and broken features
Next articleReduce the bias by using the inverse probability weighting (IPTW).